Navigation Links
MedImmune Expands Scientific and Engineering Leadership
Date:12/20/2007

oject management. In 1996, Dr. Stageman led the team that initiated the successful Phase 3 development of Faslodex(R) (fulvestrant). Later, as AZ vice president of biopharmaceutical strategy, he established a team that steered the organization's aggressive drive into biologics, including the acquisitions of both CAT and MedImmune. Dr. Stageman has served on several UK Research Council grant committees and recently served as a member of the Royal Society working party on pharmacogenetics. He is an honorary professor at the University of Manchester and holds both a bachelor of science degree in chemistry and a doctorate in physical chemistry from the University of Bristol.

Jon Green, vice president, business operations is responsible for developing and maintaining all operational, infrastructure and support activities at MedImmune's Cambridge site. Prior to joining CAT in 1992, he held a number of academic posts including on the Medical Research Council, Carshalton, and in the Department of Biochemistry at Imperial College London. Mr. Green holds a primary certification and a master's degree, both in molecular biology. He is a fellow of the Institute of Biology with chartered status.

With 14 years of experience at CAT, Jane Osbourn, Ph.D., currently serves as vice president, research, and acting head, oncology research for MedImmune's Cambridge operations. Previously, she has held a number of product and technology development posts within the organization. Dr. Osbourn completed a doctorate at the John Innes Centre for Plant Science Research in Norwich, followed by a British Heart Foundation Post doctoral fellowship at the Department of Medicine at Addenbrooke's Hospital in Cambridge. She obtained a first-class degree in natural sciences (biochemistry) from the University of Cambridge.

Paul Varley, Ph.D., currently vice president, development, Cambridge, joined CAT in 1998 as director of pharmaceutical sciences and was promoted to vice president o
'/>"/>

SOURCE MedImmune
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist(R)
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Medimmune announces phase 2 safety data for anti-RSV antibody and national RSV surveillance results
4. MedImmune to present RSV surveillance and cost-effectiveness data at American Academy of Pediatrics
5. MedImmune presents new pharmaco-economic data at AAP regarding infants at high risk for RSV
6. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
7. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
8. Rohm and Haas Expands in India
9. Concentra Expands Horizon Air Employee Health Program With On-Site Clinic
10. Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs
11. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... Johnson & Johnson and its ... lawsuit ( http://www.risperdallawsuit2014.com/ ) settlement with a California ... use of the antipsychotic medication. According to court ... third bellwether trial to involve male breast growth ... Pennsylvania’s Philadelphia Court of Common Pleas, where more ...
(Date:5/29/2015)... May 29, 2015 A group of doctors ... joined the national effort to teach this “new math” to ... U.S. have been “sickened” by the recent implementation of Common ... or hate it, Common Core is now a reality in ... Parents are now seeking ways to improve common core ...
(Date:5/29/2015)... FL (PRWEB) May 29, 2015 ... Utah, recently partnered with Stratus Video ... which will facilitate better communication and timely ... (LEP) and hearing loss. Stratus’ video remote ... in-house translators, enabling staff to quickly access ...
(Date:5/29/2015)... 29, 2015 The print component of ... circulation of approximately 250,000 and an estimated readership of ... vast social media strategy, and across a network of ... digital version of the campaign, click here. ... publication. Inside, the actress, model and producer details her ...
(Date:5/29/2015)... New York, NY (PRWEB) May 29, 2015 ... readers on the “beauty of protection”. Skin Health ... through USA Today within the markets of New York, ... reach an estimated 750,000 readers. Its digital counterpart will ... online content hubs. To read more the Skin Health ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:Doctors Discover a Cure for the Common Core 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 4Health News:Mediaplanet Launches “Skin Health” Campaign Featuring Colorescience 2
... According to a new study it is observed that ... effects for adults diagnosed with bacterial meningitis. Dexamethasone is ... patients.// The death rate among adults diagnosed with bacterial ... pneumonia. Researchers from the Academic Medical Center in Amsterdam ...
... to a new study researchers observe that stress hormones ... HPA (hypothalamus-pituitary-adrenal) axis is a hormonal system that helps ... end result is the production of the stress hormone ... is characterized by aches, pains and overwhelming tiredness. It's ...
... that a new topical medication can effectively treat signs of ... that in a long-term study of tazarotene cream, has ... 55 percent// of those tested, and it continued to show ... radiation from the sun is known to have numerous ill ...
... University observed that a chest compression belt outperforms manual ... someone has a cardiac arrest, it's vital to get ... as possible. Usually this is done by applying chest ... but these are usually not available in those vital ...
... in University of Boston observe that brain imaging sheds new ... apnoea, a person stops breathing, momentarily, many times during the ... at the back of the throat, causing upper airway obstruction. ... daytime sleepiness. It may also be a risk factor for ...
... emphysema does not help the sickest patients, according to ... lungs - the alveoli - are progressively destroyed,// leaving ... do everyday activities like climbing stairs or carrying their ... lung reduction surgery was beneficial for people with emphysema. ...
Cached Medicine News:
(Date:5/29/2015)... MENLO PARK, Calif. , May 29, ... (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical ... therapies in new orphan drug indications, presented additional ... Cancer Research (AACR) Advances in Brain Cancer Research ... product candidate VAL-083 (dianhydrogalactitol) to treat ...
(Date:5/29/2015)... 2015 Educating the community continues to ... the Advancement of Wound Care (AAWC), which was ... AAWC,s corporate partners, the Association provides medical professionals ... AAWC website at http://aawconline.org/education-for-the-generalist/ . The portal ... links to various CME/CEU educational programs. This education ...
(Date:5/28/2015)... , May 28, 2015 ... has announced the addition of Jain PharmaBiotech,s ... Companies"  to their offering.  ... (RNAi) or gene silencing involves the use ... the cell, this material is processed into ...
Breaking Medicine Technology:DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5The Association for the Advancement of Wound Care Educates the Public 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3
... N.Y., July 17 Strong National,Museum of Play ... of the,American Journal of Play, the first interdisciplinary ... The inaugural issue enters the scholarly scene ... the most prominent national,researchers and writers in the ...
... to data from other, technologies -, ... Bradmer Pharmaceuticals Inc.,(TSX: BMR), a biopharmaceutical company dedicated ... released progression free,survival (PFS) data from two previously ... (GBM) patients. As an exploratory,endpoint of the single ...
Cached Medicine Technology:Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008 2Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 2Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 3Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 4Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 5
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: